Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by CTAGE5 is a tumor-associated antigen found in cutaneous T-cell lymphoma and several other cancers. Additionally we are shipping and many more products for this protein.
Showing 10 out of 46 products:
Human Polyclonal CTAGE5 Primary Antibody for IHC, IHC (p) - ABIN4300739
Falk, Ramström, Eriksson, Uhlén, Wernérus, Hober: Targeted protein pullout from human tissue samples using competitive elution. in Biotechnology journal 2011
Show all 2 Pubmed References
Human Polyclonal CTAGE5 Primary Antibody for IHC, IHC (p) - ABIN4300738
Ek, Andréasson, Hober, Kampf, Pontén, Uhlén, Merz, Borrebaeck: From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. in Molecular & cellular proteomics : MCP 2006
In this study, we identified specific and critical residues in the Sec12 (show PREB Antibodies)-binding region of cTAGE5 (E75A K76A, K89A, and S97A) and confirmed that cTAGE5-mediated Sec12 (show PREB Antibodies) accumulation at ER exit sites is required for collagen VII (show TH Antibodies) secretion.
Data indicate that MIA2 (show MIA2 Antibodies) represents a potential novel acute phase protein (show ORM1 Antibodies) and MIA2 (show MIA2 Antibodies) expression responds to liver damage in chronic liver diseases.
The novel gene MIA2 (show MIA2 Antibodies) acts as a tumour suppressor in hepatocellular carcinoma.
population and bioinformatic analysis of MGEA6 P521A variation as a risk factor for Fahr's disease; genetic screen data show this mutation is very rare; bioinformatics analysis provided conflicting findings
cTAGE5 forms a complex with TANGO1 (MIA3 (show MIA3 Antibodies)), a previously characterized cargo receptor for collagen VII (show TH Antibodies)
HBx activates hepatoma cell growth and proliferation through repression of the potential tumor suppressor MIA2 (show MIA2 Antibodies).
22 members of an Iranian family with basal ganglia calfication as well as 100 controls were genotyped for the C>G P521A variant of CTAGE5, but none were found.
Findings suggest that the roles of MIA2 (show MIA2 Antibodies) might be based on the variety of the integrins and the subtypes of mitogen-activated protein kinase (show MAPK1 Antibodies) in oral carcinoma.
Sec12 (show PREB Antibodies) recruitment to endoplasmic reticulum exit sites is organized by its direct interaction with cTAGE5, a previously characterized collagen cargo receptor component, which functions together with TANGO1 (show MIA3 Antibodies) at endoplasmic reticulum exit sites.
These findings define an interaction between the common MIA2 (show MIA2 Antibodies)(I141M) variant and the ER stress/UPR system and specify a subgroup of PDAC patients who are more likely to benefit from adjuvant chemotherapy.
cTAGE5 deletion in pancreatic beta cells impairs proinsulin (show INS Antibodies) trafficking and insulin (show INS Antibodies) biogenesis in mice.
Mia2 (show MIA2 Antibodies) is a novel, hepatic, endoplasmic reticulum-to-Golgi trafficking protein that regulates cholesterol metabolism.
The protein encoded by this gene is a tumor-associated antigen found in cutaneous T-cell lymphoma and several other cancers. Autoantibodies against the encoded protein have been found in some cancers. Several transcript variants encoding different isoforms have been found for this gene.
cTAGE family member 5
, cutaneous T-cell lymphoma-associated antigen 5
, meningioma expressed antigen 6 (coiled-coil proline-rich)
, meningioma-expressed antigen 6/11
, protein cTAGE-5
, CTAGE family, member 5
, meningioma expressed antigen 6
, melanoma inhibitory activity protein 2
, melanoma inhibitory activity 2